Core Viewpoint - Ainos, Inc. has signed a Memorandum of Understanding (MOU) with Taiwan Tanabe Seiyaku Co., Ltd. to advance the manufacturing and market promotion of its Sjögren's syndrome drug, VELDONA® [3][6]. Market Demand for Sjögren's Syndrome Treatment - Sjögren's syndrome is an autoimmune disease with a significant unmet need for effective treatments, affecting millions globally. The global market for Sjögren's syndrome treatment is projected to reach billions of dollars in the next five years due to increasing awareness and an aging population [4]. VELDONA®'s Clinical Progress and Success - VELDONA®, a low-dose oral interferon-alpha, has shown remarkable potential in clinical trials, significantly alleviating symptoms and improving quality of life for patients. The drug has demonstrated strong tolerability and safety, laying a solid foundation for further large-scale global clinical trials [5]. Partnership with Taiwan Tanabe Seiyaku - Taiwan Tanabe Seiyaku brings extensive pharmaceutical development and market expansion experience to the partnership. The collaboration will focus on the manufacturing and promotion of VELDONA® to meet market demand, with specific details to be clarified under the MOU [6]. Global Market Impact and Future Outlook - The collaboration is expected to accelerate the global introduction of VELDONA®, ensuring timely access for patients. As more clinical data is collected, demand for VELDONA® is anticipated to solidify its position as a leading treatment for Sjögren's syndrome, potentially opening opportunities in other autoimmune diseases [7]. Ainos' Future Vision - Ainos is committed to driving medical innovation and addressing unmet medical needs globally. The partnership with Taiwan Tanabe Seiyaku is a significant milestone in Ainos' global strategy, focusing on developing breakthrough therapies to improve patient quality of life [8].
Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug